GHK basic

Compound Overview

Research Use Only. Not for Human Consumption.

GHK basic is supplied by Nexus as a 50mg research catalog variant under SKU GH50. The supplied research record identifies GHK basic as the copper-free Gly-His-Lys tripeptide: a free peptide form related to, but analytically distinct from, GHK-Cu.

• Product: GHK basic
• Available Research Size: 50mg
• SKU: GH50
• Catalog Category: Cosmetic & Skin
• Classification: Cosmetic tripeptide
• Structural Description: Gly-His-Lys free peptide, the non-copper tripeptide form related to GHK-Cu
• Sequence: GHK
• Sequence Display: Gly-His-Lys
• CAS Number: 49557-75-7
• Molecular Weight: 340.38 g/mol
• Molecular Formula: C₁₄H₂₄N₆O₄
• Physical Form: Lyophilized powder
• Use: For in-vitro research use only. Not for human consumption.

Research Background & Published Literature

The supplied research overview states that GHK basic is the copper-free Gly-His-Lys tripeptide used as a comparator or formulation component in cosmetic peptide research. Within the provided data, that comparator language is the primary research context for this SKU.

The distinction between GHK basic and GHK-Cu is central to the source record. The provided background note specifically instructs not to reuse GHK-Cu mass data for this product, because the copper-free peptide and the copper complex have different formulae, color, mass, and analytical expectations. Nexus therefore presents GHK basic with its own supplied identity fields and does not borrow copper-complex values from adjacent catalog records or public summaries.

The source record does not provide citation-level literature details such as author names, journal titles, PubMed identifiers, DOI identifiers, experimental endpoints, cell models, concentration ranges, or quantitative assay results. Because those details were not supplied, this section stays at the level of compound identity, comparator use, and documentation boundaries.

The supplied source list includes the following reference materials for background context:

Those source labels are provided here only as the research-record source list. This page does not expand beyond the facts supplied in the Nexus research data.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Maquart et al. (1993) — J Clin Invest
• Gruchlik et al. (2014) — Acta Pol Pharm
• Badenhorst et al. (2016) — Pharm Dev Technol

Storage, Handling & Stability Guidelines

Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.

• Store sealed lyophilized material at -20°C.
• Keep the material desiccated during storage.
• Protect the compound from light.
• Use a validated laboratory SOP and the applicable lot/source record for any preparation or post-reconstitution handling.
• Use a validated laboratory SOP and the applicable lot/source record for any preparation or post-reconstitution handling.

The source record does not specify a reconstitution solvent, working concentration, post-reconstitution expiration interval, vial headspace condition, or formal stability-study period. Those details should be established from current lot documentation or a laboratory-validated protocol, not from extrapolation.

Quality Assurance & Lab Verification

The Certificate of Analysis for this catalog item is pending. No provisional batch, assay, method, analyst, or release data is published in this product dossier. Check the Lab Verified archive for documentation status.